Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR-1/CD85j inhibitory receptor

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 62, Issue 2, 2007, Pages 190-196

  Morel, E ^a   Bellon T ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Amoxicillin; Hapten; Human leucocyte antigen class I; ILT2; Inhibitory natural killer receptors

Indexed keywords

AMOXICILLIN; CELL MEMBRANE PROTEIN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN LIKE TRANSCRIPT 2 RECEPTOR; NATURAL KILLER CELL RECEPTOR; PROTEIN TYROSINE PHOSPHATASE SHP 1; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONJUGATION; CONTROLLED STUDY; CYTOLYSIS; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; INCUBATION TIME; INHIBITION KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

AMOXICILLIN; ANTIGENS, CD; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMUNOCONJUGATES; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 33846141166     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01285.x     Document Type: Article

References (33)

1. Griem P, Wulferink M, Sachs B, Gonzalez JB, Gleichmann E. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunol Today 1998;19:133-141.
2. Gruchalla RS. Drug allergy. J Allergy Clin Immunol 2003;111:S548- 559.
3. Gerber PO, Pichler WJ. Cellular mechanisms of T cell mediated drug hypersensitivity. Curr Opin Immunol 2004;16:732-737.
4. Batchelor FR, Janet MD, Gazzard D. Penicillin allergy: the formation of the penicilloyl determinant. Nature 1965;206:362-364.
5. López-Botet M, Bellón T, Llano M, Navarro F, García P, de Miguel M. Paired inhibitory an triggering NK cell receptors for HLA class I molecules. Human Immunol 2000;61:7-17.
6. Colonna M, Navarro F, Bellón T, Llano M, García P, Samaridis J et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997;186:1809-1818.
7. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998;160:3096-3100.
8. Lepin EJ, Bastin JM, Allan DS, Roncador G, Braud VM, Mason DY et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 2000;30:3552-3561.
9. Ugolini S, Vivier E. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr Opin Immunol 2000;12:295-300.
10. Mingari MC, Pietra G, Moretta L. Human cytolitic T lymphocytes expressing HLA class-I-specific inhibitory receptors. Curr Opin Immunol 2005;17: 312-319.
11. Bellón T, Kitzig F, Sayos J, Lopez-Botet M. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 2002;168: 3351-3359.
12. Saverino D, Fabbi M, Ghiotto F, Merlo A, Bruno S, Zarcone D et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and downregulates their functions. J Immunol 2000;165:3742-3755.
13. Dietrich J, Cella M, Colonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol 2001;166:2514-2521.
14. Ince MN, Harnisch B, Xu Z, Lee SK, Lange C, Moretta L et al. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 2004;112:531-542.
15. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996;24:406-415.
16. Mayorga C, Obispo T, Jimeno L, Blanca M, Moscoso del Prado J, Carreira J et al. Epitope mapping of beta-lactam antibiotics with the use of monoclonal antibodies. Toxicology 1995;97:225-234.
17. Carretero M, Palmieri G, Llano M, Tullio V, Santoni A, Geraghty DE et al. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine- phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur J Immunol 1998;28: 1280-1291.
18. Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998;110:203-206.
19. Blanca M, Cornejo-García JA, Torres MJ, Mayorga C. Specificities of B cell reactions to drugs. The penicillin model. Toxicology 2005;209:181-184.
20. Cavani A, de Pita O. The role of T cells in drug reaction. Curr Allergy Asthma Rep 2006;6:20-24.
21. Britschgi M, von Greyerz S, Burkhart C, Pichler WJ. Molecular aspects of drug recognition by specific T cells. Curr Drug Targets 2003;4:1-11.
22. Brooks BM, Flanagan BF, Thomas AL, Coleman JW. Penicillin conjugates to interferon-γ and reduces its activity: a novel drug-cytokine interaction. Biochem Biophys Res Commun 2001;288:1175-1181.
23. Brooks BM, Thomas AL, Colema JW. Benzylpenicillin differentially conjugates to IFN-γ, TNF-α, IL-1β, IL-4 and IL-13 but selectively reduces IFN-γ activity. Clin Exp Immunol 2003;131:268- 274.
24. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000;290:84-89.
25. Chapman TL, Heikema AP, Bjorkman PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999;11: 603-613.
26. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003;100:8856-8861.
27. Tenca C, Merlo A, Merck E, Bates EEM, Saverino D, Simone R et al. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J Immunol 2005;174:6757-6763.
28. Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, Borges L. The MHC class I binding proteins LIR-1 ad LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol 1998;28:3423-3434.
29. Deng L, Mariuzza RA. Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol 2006;18:159-166.
30. Betser-Cohen G, Katz G, Gonen-Gross T, Stern N, Arnon TI, Achdout H et al. Reduced KIR2DL1 recognition of MHC class I molecules presenting phosphorylated peptides. J Immunol 2006;176: 6762-6769.
31. Martin S, Lappin MB, Kohler J, Delattre V, Leicht C, Preckel T et al. Peptide immunization indicates that CD8+ T cells are the dominant effector cells in trinitrophenyl-specific contact hypersensitivity. J Invest Dermatol 2000;115:260-266.
32. Saint-Mezard P, Rosiers A, Krasteva M, Berard F, Dubois B, Kaiserlian D et al. Allergic contact dermatitis. Eur J Dermatol 2004;14:284-295.
33. Kuechler PC, Britschgi M, Schmid S, Hari Y, Grabscheid B, Pichler WJ. Cytotoxic mechanisms in different forms of T-cell-mediated allergies. Allergy 2004;59:613-622.